Dean Schorno
Director of Finance/CFO bei RIGEL PHARMACEUTICALS, INC.
Vermögen: 596 279 $ am 31.03.2024
Aktive Positionen von Dean Schorno
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RIGEL PHARMACEUTICALS, INC. | Director of Finance/CFO | 29.05.2018 | - |
Karriereverlauf von Dean Schorno
Ehemalige bekannte Positionen von Dean Schorno
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Chief Operating Officer | 17.08.2015 | 01.05.2018 |
Director of Finance/CFO | 17.08.2015 | 01.05.2018 | |
ADAPTIVE BIOTECHNOLOGIES CORPORATION | Director of Finance/CFO | 24.06.2014 | 10.08.2015 |
GENOMIC HEALTH, INC. | Director of Finance/CFO | 10.01.2011 | 01.07.2014 |
Investor Relations Contact | 01.07.2003 | 01.07.2014 | |
Public Communications Contact | 01.07.2003 | 01.07.2014 | |
Corporate Officer/Principal | 01.02.2010 | 10.01.2011 |
Ausbildung von Dean Schorno
Golden Gate University | Graduate Degree |
University of California, Berkeley | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Director of Finance/CFO | 4 |
Investor Relations Contact | 1 |
Public Communications Contact | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
RIGEL PHARMACEUTICALS, INC. | Health Technology |
ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
Private Unternehmen | 2 |
---|---|
Genomic Health, Inc.
Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
- Börse
- Insiders
- Dean Schorno
- Erfahrung